Philips
(NYSE: PHG)
today announced a new partnership with Biotronik.
The companies teamed up to expand the range of cardiovascular devices available for Philips SymphonySuite customers. Biotronik develops products and services for treating cardiovascular and endovascular diseases.
Philips designed its SymphonySuite for opening and expanding cardiovascular office-based labs OBLs and ambulatory surgery centers (ASCs). The Amsterdam-based medtech giant says it features a full range of high-performing, highly specialized equipment and devices. It also offers personalized services, financing options, site planning, ongoing operational support and device programs.
“Philips is committed to expanding access to care through its innovative solutions and Biotronik’s alliance adds additional devices, including a cardiac rhythm management portfolio, to SymphonySuite,” said Chris DeCarolis, head of procedural solutions for image-guided therapy at Philips. “We will continue to evolve to stay ahead of the needs of physicians and patients and provide cardiovascular equipment, devices and services in out-of-hospital settings while reducing cost pressures via innovative business models.”
The companies say the combination of SymphonySuite and Biotronik’s offerings could provide more options to individualize patient care. They also aim to create treatment strategies for low-risk cardiac procedures performed out-of-hospital in settings like OBLs and ASCs.
Out-of-hospital care settings increase access to care and allow for a personalized patient experience, Philips said. They can also lead to a lower risk of hospital-acquired infections. Philips and Biotronik believe the savings provided by this collaboration can drive lower costs for patients.
“Through Biotronik’s innovative cardiovascular technologies, we’re committed to partnering with outpatient sites of service. Aligning with Philips will allow us to bring greater value to our outpatient customers, particularly those with capital equipment needs for ASC and OBL facilities,” said Atul Suri, VP of commercial excellence at Biotronik.